Partners Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.59M Buy
6,012
+4,353
+262% +$1.15M 0.17% 103
2026
Q2
$421K Hold
1,659
– – 0.41% 63
2026
Q1
$406K Sell
1,659
-2
-0.1% -$466 0.42% 62
2025
Q4
$344K Sell
1,661
-157
-9% -$31K 0.36% 72
2025
Q3
$337K Sell
1,818
-355
-16% -$60.8K 0.33% 83
2025
Q2
$333K Hold
2,173
– – 0.38% 72
2025
Q1
$360K Sell
2,173
-60
-3% -$9.39K 0.41% 69
2024
Q4
$323K Buy
+2,233
New +$346K 0.37% 76

Other funds holding JNJ

Partners Wealth Management's JNJ Position: Q3 2026 in Review

Partners Wealth Management increased its Johnson & Johnson (JNJ) stake by 262% in Q3 2026, buying an estimated $1.15M and bringing the position to 6,012 shares worth $1.59M. The position accounts for 0.17% of the portfolio, ranked #103.

Partners Wealth Management first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Partners Wealth Management held 6,012 shares of Johnson & Johnson worth $1.59M as of Q3 2026.
  • Partners Wealth Management bought 4,353 Johnson & Johnson shares in Q3 2026, an estimated $1.15M.
  • Johnson & Johnson made up 0.17% of Partners Wealth Management's portfolio in Q3 2026, its #103 holding.
  • Partners Wealth Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Partners Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.